ストックスクリーナーアプリを入手
4.30
1.24%
0.0528
前日終値:
$4.2472
開ける：
$4.485
24時間の取引高:
9,273
Relative Volume:
0.52
時価総額：
$8.68M
収益：
$5.27M
当期純損益:
$-7.98M
株価収益率:
-6.0657
EPS:
-0.7089
ネットキャッシュフロー:
$-7.04M
1週間 パフォーマンス:
-0.92%
1か月 パフォーマンス:
+6.17%
6か月 パフォーマンス:
+8.59%
1年 パフォーマンス:
+8.31%
1日の値動き範囲:
$4.24
$4.485
1週間の範囲:
$4.13
$4.60
52週間の値動き範囲:
$2.66
$4.73
Neurometrix Inc Stock (NURO) Company Profile
NURO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NURO
Neurometrix Inc
|
4.30 | 8.68M | 5.27M | -7.98M | -7.04M | -0.7089 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Neurometrix Inc Stock (NURO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2017-10-20 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-06-28 | 開始されました | Rodman & Renshaw | Buy |
| 2015-09-11 | 開始されました | Maxim Group | Buy |
| 2012-02-27 | 開始されました | Dawson James | Buy |
Neurometrix Inc (NURO) 最新ニュース
NeuroMetrix Q3 Loss Narrows Y/Y, Quell Sales Drives Growth - MSN
NeuroMetrix (NASDAQ:NURO) Now Covered by Analysts at StockNews.com - Defense World
NeuroMetrix (NASDAQ:NURO) Coverage Initiated at StockNews.com - Defense World
NeuroMetrix revenue down 51% in Q3 2024 - Medical Buyer
NeuroMetrix revenue increases 50% to USD 184,000 in Q3 2024 - Medical Buyer
NeuroMetrix Third Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.66 loss in 3Q 2023) - Yahoo Finance
NeuroMetrix Q3 2024: Mixed Results Amid Strategic Review - TipRanks
NeuroMetrix Reports Q3 2024 Business Highlights - The Manila Times
NeuroMetrix Q3 Revenue Falls 51% Despite Quell Growth; Cost-Cutting Efforts Show Promise | NURO Stock News - StockTitan
NeuroMetrix (NASDAQ:NURO) Earns Sell Rating from Analysts at StockNews.com - Defense World
NeuroMetrix stock touches 52-week high at $4.73 - Investing.com India
NeuroMetrix stock touches 52-week high at $4.73 By Investing.com - Investing.com UK
StockNews.com Initiates Coverage on NeuroMetrix (NASDAQ:NURO) - Defense World
NeuroMetrix (NASDAQ:NURO) Stock Price Crosses Above 200-Day Moving Average – Here’s Why - Defense World
Neuromuscular Electrical Muscle Stimulator Industry likely to thriving future growth - Elektrotransports.lv
Transcutaneous Electrical Nerve Muscle Stimulation Industry Size, Status and Business Outlook - Elektrotransports.lv
Interferential Muscle Stimulator Industry Report By Type, Application and Geography - Elektrotransports.lv
Diabetic Neuropathy Market May See a Big Move | Cephalon, GlaxoSmithKline, NeuroMetrix - openPR
NeuroMetrix (NASDAQ:NURO) Now Covered by StockNews.com - Defense World
Financial Analysis: NeuroMetrix (NASDAQ:NURO) versus Sensus Healthcare (NASDAQ:SRTS) - Defense World
NeuroMetrix Inc. | RapidScan | Dec 2006 - Photonics.com
Muscle Stimulator Market Size, Share, Growth Insights - openPR
NeuroMetrix (NASDAQ:NURO) Research Coverage Started at StockNews.com - Defense World
Internal Neuromodulation Devices Market Size, Trends And Forecast 2024-2033 - WhaTech
One Point One Solutions shares gain as company expands healthcare verticalCheck details - MSN
Rhumbline Advisers Grows Stake in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World
Kalikesh Singh wins NRAI President election; onus on him to take shooting to next level - RevSportz
Kalikesh Narayan Singh Deo elected NRAI President - IndianShooting.com
Neuronetics Expands TMS Coverage, Enhancing Access for MDD Treatment - MyChesCo
Mobile-health Network Solutions Receives Nasdaq Delinquency Notice for Minimum Bid Price Requirement - Vancity Buzz
High ROE & high ROCE multibagger stock in focus as company bags pilot export orders worth Rs 2,40,00,000 from clients in Europe, Middle East and USA - Dalal Street Investment Journal
A phone camera as health screening device? Healthtech agency’s new home displays innovations - The Straits Times
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by State of New Jersey Common Pension Fund D - Defense World
Global Electrotherapy System Research Report 2024: A $1.65 Billion Market by 2030 - GlobeNewswire Inc.
Exploring Opportunities in the Muscle Stimulation Devices - openPR
Muscle Stimulator Market Statistical Forecast, Trade Analysis - openPR
NeuroMetrix (STU:NLZ0) Shares Outstanding (EOP) : 2.02 Mil (As of Jun. 2024) - GuruFocus.com
NeuroMetrix (NASDAQ:NURO) Receives New Coverage from Analysts at StockNews.com - Defense World
NeuroMetrix continues strategic review to boost value - Investing.com India
NeuroMetrix stock plunges to 52-week low of $2.66 By Investing.com - Investing.com Canada
NeuroMetrix Reiterates its Review of Strategic Alternatives - StockTitan
NeuroMetrix stock plunges to 52-week low of $2.66 - Investing.com
NeuroMetrix, Inc. (NURO) Q2 2024 Earnings Call Transcript - Seeking Alpha
NeuroMetrix Second Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.56 loss in 2Q 2023) - Yahoo Finance
Smart Medical Devices Market SWOT and PESTAL Analysis | 2032 - WICZ
Muscle Stimulation Devices Market Detailed Size Estimates - openPR
NURO Stock Earnings: NeuroMetrix Reported Results for Q2 2024 - MSN
NeuroMetrix Reports Q2 2024 Business Highlights and Update on Review of Strategic Options - StockTitan
NeuroMetrix reports Q2 revenue $769,148 vs. $1.66M last year - TipRanks
NeuroMetrix (NURO) Scheduled to Post Earnings on Tuesday - Defense World
Neurometrix Inc (NURO) 財務データ
収益
当期純利益
現金流量
EPS
0.65%
大文字化:
|
ボリューム (24 時間):